Email This Article

Headlines & Perspectives
Barr Labs Says FDA Rejects New Cenestin Dosage
By Nat Worden
06/03/03 - 02:35 PM EDT
The company will meet with the agency to discuss its next course of action.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,237.98 1,092.76 2,151.60 34.82
Oil *
77.43
UP
11.04
DOWN
0.31
DOWN
2.46
DOWN
0.04
10 Yr
3.48%
SPDR Gold
108.30
+0.11%
-0.03%
-0.11%
-0.11%
Data delayed 20 minutes

Brokerage Partners